AtaiBeckley Inc. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
3.920
+0.120 (3.16%)
At close: Jun 12, 2026, 4:00 PM EDT
3.940
+0.020 (0.51%)
After-hours: Jun 12, 2026, 7:51 PM EDT
AtaiBeckley Revenue
AtaiBeckley had revenue of $954.00K in the quarter ending March 31, 2026, a decrease of -38.65%. This brings the company's revenue in the last twelve months to $3.49M, up 87.22% year-over-year. In the year 2025, AtaiBeckley had annual revenue of $4.09M with 1,227.60% growth.
Revenue (ttm)
$3.49M
Revenue Growth
+87.22%
P/S Ratio
413.77
Revenue / Employee
$35,232
Employees
99
Market Cap
1.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.09M | 3.78M | 1,227.60% |
| Dec 31, 2024 | 308.00K | -6.00K | -1.91% |
| Dec 31, 2023 | 314.00K | 81.00K | 34.76% |
| Dec 31, 2022 | 233.00K | -20.14M | -98.86% |
| Dec 31, 2021 | 20.38M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novavax | 596.34M |
| Ardelyx | 427.68M |
| Immunocore Holdings | 412.81M |
| UroGen Pharma | 140.49M |
| KalVista Pharmaceuticals | 114.48M |
| Septerna | 72.26M |
| Vir Biotechnology | 65.50M |
| Monte Rosa Therapeutics | 42.95M |
ATAI News
- 9 days ago - AtaiBeckley Transcript: AGM 2026 - Transcripts
- 9 days ago - AtaiBeckley Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 16 days ago - AtaiBeckley Launches Patient Impact Grant Program for Mental Health Non-Profit Organizations - GlobeNewsWire
- 17 days ago - AtaiBeckley to Participate in Upcoming Investor Conferences in June 2026 - GlobeNewsWire
- 4 weeks ago - Psychedelic: Compass Pathways, AtaiBeckley, GH Research report earnings - TheFly
- 4 weeks ago - AtaiBeckley reports Q1 EPS (8c), consensus (11c) - TheFly
- 4 weeks ago - AtaiBeckley Reports First Quarter 2026 Financial Results and Provides Program and Business Update - GlobeNewsWire
- 4 weeks ago - AtaiBeckley Quarterly report: Q1 2026 - Filings